During the past decade, Corporacio Sanitaria Parc Tauli conducted 286 clinical trials. In the 10-year time frame, 286 clinical trials started and 94 clinical trials were completed, i.e. on average, 32.9% percent of trials that started reached the finish line to date. In the past 5 years, 143 clinical trials started and 64 clinical trials were completed. i.e. 44.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Corporacio Sanitaria Parc Tauli" #1 sponsor was "Corporacion Parc Tauli" with 65 trials, followed by "Pfizer" with 26 trials sponsored, "Janssen Research & Development, LLC" with 21 trials sponsored, "Spanish Breast Cancer Research Group" with 14 trials sponsored and "PETHEMA Foundation" with 14 trials sponsored. Other sponsors include 275 different institutions and companies that sponsored additional 158 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Corporacio Sanitaria Parc Tauli" #1 collaborator was "Hoffmann-La Roche" with 8 trials as a collaborator, "Hospital Parc Taulí, Sabadell" with 6 trials as a collaborator, "Astellas Pharma Inc" with 5 trials as a collaborator, "Hospital Universitari de Bellvitge" with 5 trials as a collaborator and "Instituto de Salud Carlos III" with 5 trials as a collaborator. Other collaborators include 270 different institutions and companies that were collaborators in the rest 225 trials.

According to Clinical.Site data, the most researched conditions in "Corporacio Sanitaria Parc Tauli" are "Breast Cancer" (16 trials), "Cystic Fibrosis" (10 trials), "Crohn's Disease" (8 trials), "Prostate Cancer" (8 trials) and "Colorectal Cancer" (7 trials). Many other conditions were trialed in "Corporacio Sanitaria Parc Tauli" in a lesser frequency.

Most popular intervention types in "Corporacio Sanitaria Parc Tauli" are "Drug" (263 trials), "Other" (65 trials), "Biological" (33 trials), "Procedure" (31 trials) and "Device" (18 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (71 trials), "Carboplatin" (10 trials), "Prednisone" (9 trials), "Capecitabine" (7 trials) and "Cyclophosphamide" (7 trials). Other intervention names were less common.

The vast majority of trials in "Corporacio Sanitaria Parc Tauli" are 357 trials for "All" genders, 34 trials for "Female" genders and 27 trials for "Male" genders.

Currently, there are NaN active trials in "Corporacio Sanitaria Parc Tauli". 2 are not yet recruiting, 78 are recruiting, 46 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 209 completed trials in Corporacio Sanitaria Parc Tauli, undefined suspended trials, and 34 terminated clinical trials to date.

Out of the total trials that were conducted in Corporacio Sanitaria Parc Tauli, 8 "Phase 1" clinical trials were conducted, 88 "Phase 2" clinical trials and 130 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 39 trials, and there were also 43 trials that are defined as “Not Applicable".

Corporacio Sanitaria Parc Tauli has several departments that took part in Clinical trials: "Corporacio Sanitaria Parc Tauli; Servicio de Oncologia" - 34 trials, "Corporacio Sanitaria Parc Tauli; Servicio de Hepatologia" - 2 trials, "Corporacion Sanitaria Parc Tauli Unidad de Endocrinologia" - 2 trials, "Corporacio Sanitaria Parc Tauli de Sabadell, Servicio de Reumatologia" - 2 trials, "Corporacio Sanitaria Parc Tauli; Servicio de Hematologia" - 2 trials